1.07
+5.94%
Close of 9 Nov 2026, in CHF
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About SHL Telemedicine
Its shares trade on SIX under the ticker SHLTN.SW. It has been listed since 15 November 2000. In the fiscal year to 31 December 2025, it reported revenue of $61.5m and a net loss of $16.1m. At that date it held total assets of $84.6m and shareholders' equity of $43.7m.
SHL Telemedicine Ltd. is engaged in the development and market of advanced personal telemedicine solutions which focuses on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 15 Nov 2000
- Employees
- 448
- Website
- shl-telemedicine.com ↗
Leadership
Pay as last reported
- Dr. Itamar OfferNon-Executive Chairman of the Board$9,103
- Mr. David ArnonChief Executive Officer$606,359
- Mr. Lior HaalmanChief Financial Officer
- Mr. Bernd AltpeterManaging Director of SHL Telemedizin, Germany
- Prof. Amir LermanNon-Executive Director$44,024
- Mr. Ido NoubergerNon-Executive Director
- Mr. Nir RotenbergNon-Executive Director
- Mr. Yehoshua AbramovichNon-Executive Independent Director$72,432
- Ms. Orna CarniNon-Executive Independent Director$2,513
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 29
- Environment
- 11
- Social
- 39
- Governance
- 39
- Women in the workforce
- 61%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- SHL Telemedicine Ltd has established itself as a leading provider of telemedicine services, offering convenient and accessible healthcare solutions.
- The company has developed a robust technological platform, facilitating seamless integration with healthcare providers and patients.
- SHL Telemedicine has a strong network of skilled healthcare professionals who deliver high-quality medical consultations remotely.
- The company's telemedicine services have the potential to improve healthcare access in remote areas and reduce overcrowding in hospitals.
Weaknesses
- SHL Telemedicine may face resistance from traditional healthcare providers who are skeptical about the effectiveness and security of telemedicine.
- The company might experience challenges in gaining trust and acceptance from patients who prefer in-person consultations and are unfamiliar with telemedicine.
- The effectiveness of telemedicine heavily relies on reliable internet connectivity, which can be a barrier in some regions.
Opportunities
- The increasing adoption of digital technologies and the demand for convenient healthcare services present a significant growth opportunity for SHL Telemedicine.
- The company can expand its services globally, targeting underserved regions with limited access to healthcare facilities.
- Telemedicine has the potential to improve healthcare outcomes and reduce healthcare costs, making it an attractive option for insurance providers and government healthcare systems.
Threats
- SHL Telemedicine faces competition from other telemedicine providers and traditional healthcare institutions that are also expanding their telemedicine offerings.
- Changes in regulations and reimbursement policies may impact the financial viability of the telemedicine industry.
- Data privacy and security concerns can pose a threat to the adoption of telemedicine services, leading to potential breaches and loss of patient trust.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.